1529 - Prevalence of BTK, PLCG2, and BCL2 mutations in CLL patients in Croatia - KROHEM study

Co-Author(s)

BG

Branimir Gizdic, PhD

University Hospital Dubrava
Zagreb, Croatia
IA

Ivona Aric Zrna

University Hospital Dubrava
Zagreb, Grad Zagreb, Croatia
MN

Mia Nizetic Govic

University Hospital Dubrava
Zagreb, Dubrovacko-Neretvanska, Croatia
PV

Petra Veic, MD

University Hospital Dubrava
Zagreb, Grad Zagreb, Croatia
BD

Barbara Dreta, MD

University Hospital Centre Zagreb
Zagreb, Croatia
IM

Inga Mandac-Smoljanovic, MD, PhD

Clinical Hospital Merkur
Zagreb, Croatia
SB

Sandra Basic-Kinda, MD, PhD

University Hospital Centre Zagreb
Zagreb, Croatia
RB

Renata Babok-Flegaric, MD

General Hospital Varazdin
Varazdin, Varazdinska, Croatia
HM

Hana Matijaca, MD

University Hospital Center Sisters of Mercy
Zagreb, Grad Zagreb, Croatia
DG

Dragana Grohovac, MD

University Hospital Centre Rijeka, Croatia
MM

Martina Marjanović, MD

General Hospital Bjelovar
Bjelovar, Bjelovarsko-Bilogorska, Croatia
JS

Jasminka Sincic-Petricevic, MD

University Hospital Centre Osijek
Osijek, Croatia
ES

Ena Soric, MD

Resident
University Hospital Dubrava
Zagreb, Croatia
MI

Marija Ivic, MD

University Hospital Dubrava
Zagreb, Croatia
VP

Vlatko Pejša, MD, PhD

University Hospital Dubrava
Zagreb, Croatia
Igor Aurer, MD, PhD

University Hospital Centre Zagreb and Medical School, University of Zagreb
Zagreb, Croatia